Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 known ✓ | O43570 | 5/20 | 0.51 |
| ▸ | CA1 known ✓ | P00915 | 5/20 | 0.51 |
| ▸ | CA2 known ✓ | P00918 | 5/20 | 0.51 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.97 |
| ▸ | HPGD | P15428 | 2/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.97 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | CASP6 | P55212 | 2/20 | 0.58 |
| ▸ | NSD2 | O96028 | 1/20 | 0.58 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.58 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 6/20 | 0.51 |
| ▸ | CTSB | P07858 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7202147 | 1.00 | ALDH1A1 (0.97) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL10337685 | 0.98 | ALDH1A1 (1.00) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL29376983 | 0.98 | ALDH1A1 (1.00) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL93200 | 0.98 | ALDH1A1 (1.00) | ALDH1A1HPGDTDP1GAACASP6 | |
| Water SCHEMBL18832246 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL11527723 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL146864 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HPGDTDP1GAACASP6 | |
| Water SCHEMBL5050373 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL7920625 | 0.97 | ALDH1A1 (0.97) | ALDH1A1HPGDTDP1GAACASP6 | |
| SCHEMBL7920628 | 0.88 | ALDH1A1 (0.75) | ALDH1A1HPGDTDP1GAACASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108658-A1 | INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS | Prism Inks, Inc. (US) | 2025-04-03 | — | — | US | disclosed |
| WO-2022188373-A1 | METHOD FOR DETECTING WATER-SOLUBLE ANIONIC SYNTHETIC PIGMENT IN FOOD | 广州市食品检验所（广州市酒类检测中心） | 2022-09-15 | — | — | WO | disclosed |
| EP-2710996-B1 | Sunscreen compositions comprising colour pigments | BASF SE (DE) | 2022-08-17 | — | — | EP | disclosed |
| US-11384033-B2 | Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants | BASF SE (DE) | 2022-07-12 | — | — | US | disclosed |
| CN-107108388-B | Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect | 巴斯夫欧洲公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-112374933-A | Composition comprising (thio) phosphoric triamide and other compounds such as amines and colorants with improved urease-inhibiting effect | 巴斯夫欧洲公司 | 2021-02-19 | — | — | CN | disclosed |
| EP-3763692-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO) PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| EP-3763691-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2021-01-13 | — | — | EP | disclosed |
| EP-3725756-A2 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING AMINES, OR COLORANTS, AND AN ADDUCT OF THE THREE COMPOUNDS N-(N-BUTYL) THIOPHOSPHORIC ACID TRIAMIDE (NBPT), UREA, AND FORMALDEHYDE | BASF SE (DE) | 2020-10-21 | — | — | EP | disclosed |
| US-20200157018-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2020-05-21 | — | — | US | disclosed |
| EP-1083861-B1 | HYDROUS COSMETIC OR PHARMACEUTICAL STICKS | BEIERSDORF AG (DE) | 2005-09-21 | — | — | EP | disclosed |
| US-20050002974-A1 | Itch-relieving cosmetic or dermatological preparation | BEIERSDORF AG (DE) | 2005-01-06 | — | — | US | disclosed |
| EP-1458332-A1 | CLEANING PRODUCTS BASED ON MICROEMULSIONS THAT CONTAIN OIL | Beiersdorf AG (DE) | 2004-09-22 | — | — | EP | disclosed |
| EP-1450760-A2 | ITCH-RELIEVING COSMETIC AND DERMATOLOGICAL PREPARATIONS | Beiersdorf AG (DE) | 2004-09-01 | — | — | EP | disclosed |
| WO-2004024110-A1 | COSMETIC PREPARATION BASED ON OIL-CONTAINING MICROEMULSIONS | BEIERSDORF AG (DE) | 2004-03-25 | — | — | WO | disclosed |
| WO-2003051319-A1 | CLEANING PRODUCTS BASED ON MICROEMULSIONS THAT CONTAIN OIL | BEIERSDORF AG (DE) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003045349-A2 | ITCH-RELIEVING COSMETIC AND DERMATOLOGICAL PREPARATIONS | BEIERSDORF AG (DE) | 2003-06-05 | — | — | WO | disclosed |
| EP-1310235-A2 | Emulsifier-free cosmetic and dermatological sunscreen formulations comprising hydroxybenzophenones | Beiersdorf AG (DE) | 2003-05-14 | — | — | EP | disclosed |
| EP-1083861-A1 | HYDROUS COSMETIC OR PHARMACEUTICAL STICKS | Beiersdorf Aktiengesellschaft (DE) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999065454-A1 | HYDROUS COSMETIC OR PHARMACEUTICAL STICKS | BEIERSDORF AG (DE) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050002974-A1 | Itch-relieving cosmetic or dermatological preparation | ITCH, SMURF2, SMURF1 | CA12 1646/4885CA1 3683/4885CA2 2805/4885 |
| US-20200157018-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | SLC14A1, XDH, PNP | CA12 314/4885CA1 464/4885CA2 162/4885 |
| US-11384033-B2 | Compositions with improved urease-inhibiting effect comprising (thio)phosphoric acid triamide and further compounds such as amines and colorants | SLC14A1, XDH, PNP | CA12 314/4885CA1 464/4885CA2 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.